Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Midazolam Infusion for CRPS
NCT05945147Phase 2Withdrawn
- Sponsor
- Stanford University
- Start
- Jan 2099
- Primary completion
- Apr 2099
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in complex regional pain syndrome (CRPS), sponsored by Stanford University. Planned start Jan 2099; status: withdrawn.
02
Drugs
ketamine
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT05945147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05945147.